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JOURNAL OF HEPATOLOGYMight some of the beneﬁcial effects of the Mediterranean diet on
non-alcoholic fatty liver disease be mediated by reduced iron stores?to include assessment of the dietary intervention on iron status
and also to investigate the particular effects of iron depletion.
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Ryan and colleagues [1] found that a Mediterranean diet pattern
reduced liver steatosis and improved insulin sensitivity in an
insulin resistant population with non-alcoholic fatty liver disease
(NAFLD), compared to current dietary advice. We suggest that
lower body iron stores induced by components of the Mediterra-
nean diet may be involved in this beneﬁcial effect. In this setting,
it has been proposed that the balance between the average bio-
availability of dietary iron and the overall effects of inhibitors
and enhancers of iron absorption may lead to lower iron stores
in people consuming a Mediterranean dietary pattern [2].
In fact, it has been reported that elderly men from Crete, in the
Mediterranean south of Europe had consistently lower levels of
indicators of oxidative stress and iron status than elderly men
from Zutphen in the north of Europe [3]. In particular, serum fer-
ritin, a good marker of the iron stored in the body, were 2-fold
lower in men from Crete than in men from Zutphen (69.8 lg/L
and 134.2 lg/L, respectively).
Mounting evidence suggests a link between serum ferritin,
insulin resistance, and NAFLD [4]. Body iron excess has frequently
been found in patients with metabolic syndrome [5], with serum
ferritin showing a linear increase with the increasing number of
metabolic syndrome features [5]. Moreover, it has been sug-
gested that the relation between serum ferritin and most of met-
abolic syndrome features might be mediated by the presence of
NAFLD at population-based level [6]. Excessive hepatic iron
accumulation in NAFLD can be one of the potential cofactors
involved in the enhanced oxidative stress, which triggers liver
cell necrosis and activation of hepatic stellate cells, both leading
to ﬁbrosis [7].
One of the largest studies evaluating iron and liver histology
in NAFLD demonstrated that elevated serum ferritin identiﬁed
NAFLD patients with more advanced disease [8]. Previous studies
have shown a beneﬁt of iron reduction therapy on NAFLD sever-
ity and insulin sensitivity [9]. Furthermore, iron depletion by
phlebotomy has been recently found to impact liver histology,
which is considered the gold standard for evaluating the efﬁcacy
of liver disease treatment. A small phase II study of phlebotomy
carried out to achieve near-iron depletion (serum ferritin
650 lg/L) demonstrated statistically signiﬁcant reductions in
the NAFLD activity score (NAS), transaminases, serum ferritin,
and hepatic iron concentration [10]. Although not statistically
signiﬁcant, improvements in steatosis, lobular inﬂammation,
hepatocyte ballooning, and ﬁbrosis were all in the predicted
direction. Of note, these beneﬁcial effects were reached in
patients with a relatively mild overall degree of iron overload
and liver disease at baseline (mean NAS = 3.8).
Therefore, lower body iron stores induced by dietary compo-
nents of Mediterranean diet could be involved in the beneﬁcial
action of this dietary pattern. It is important in future studies
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